For people with multiple sclerosis (MS), hearing a doctor tell them they are experiencing brain atrophy—an important, predictive biomarker of MS disease progression—can trigger debilitating fear and anxiety.
Nov 14, 2022
0
5
If you compare the brain of someone who has died from neurodegenerative disease to that of a healthy person, you can't miss the difference: In the case of severe Alzheimer's, the brain will be noticeably smaller, with large ...
Jul 28, 2022
0
16
Chronic low back pain (CLBP) is associated with reductions in brain volume in areas involved in pain processing, reports a study in Pain, the official publication of the International Association for the Study of Pain (IASP).
Mar 29, 2022
0
105
Researchers from the Florey Institute of Neuroscience and Mental Health have advanced understanding of the biological mechanisms underlying a rare neurological disease called Multiple System Atrophy (MSA), finding evidence ...
Sep 30, 2021
0
2
Frontotemporal dementia is the second most common cause of dementia in the working age population. Its diagnostics are complicated by the similar symptoms presented by patients with psychiatric disorders or other neurodegenerative ...
Jul 2, 2021
0
4
An international study has found a link between the brain's network connections and gray matter atrophy caused by certain types of epilepsy, a major step forward in our understanding of the disease.
Dec 2, 2020
0
52
Trinity researchers are studying how the brain re-wires itself in neurological disease. The team is building treatments for today's more common global conditions like motor neurone disease (MND/ALS) and spinal muscular ...
Nov 17, 2020
0
30
study calls for screening of older MS patients for cognitive decline and age-associated neurological conditions
Mar 5, 2020
0
7
In a new study, UC San Francisco scientists used maps of brain connections to predict how brain atrophy would spread in individual patients with frontotemporal dementia (FTD), adding to growing evidence that the loss of brain ...
Oct 14, 2019
0
107
(HealthDay)—Simvastatin's beneficial effects on clinical outcomes and brain atrophy in patients with multiple sclerosis (MS) are largely independent of cholesterol levels, according to a post hoc study published in the ...
Jun 7, 2019
0
4
